Scientists have discovered that a loss of smell may signal Alzheimer’s disease years before memory problems begin, offering a potential breakthrough in early diagnosis.

The study, led by researchers at the German Center for Neurodegenerative Diseases (DZNE), found that smell-related changes occur in the very early stages of the disease. Therefore, this symptom could help identify at-risk individuals much sooner than current methods.

Researchers found that smell loss begins before cognitive decline becomes noticeable.

This finding highlights the importance of sensory changes as early indicators of neurological conditions.

🧠 Immune System Damages Brain Connections

The research revealed that the brain’s own immune cells, known as microglia, play a key role in this process.

These cells mistakenly attack and destroy nerve fibers responsible for transmitting smell signals. As a result, the connection between the olfactory bulb and the locus coeruleus becomes disrupted.

Meanwhile, scientists observed that this damage starts long before traditional Alzheimer’s symptoms appear. Consequently, it provides a new understanding of how the disease develops at an early stage.

🔬 Molecular Changes Trigger Immune Response

The study identified a critical biological trigger behind this immune reaction. Researchers found that a molecule called phosphatidylserine shifts to the outer surface of nerve cell membranes.

This shift acts as an “eat-me” signal, prompting microglia to remove the affected nerve fibers.

Moreover, scientists believe that this change results from abnormal activity in neurons caused by Alzheimer’s disease. Therefore, the immune system mistakenly identifies these neurons as damaged.

📊 Evidence From Multiple Scientific Methods

To confirm their findings, researchers used a combination of advanced scientific approaches.

They analysed:

• Mouse models with Alzheimer’s-like conditions
• Brain tissue from deceased patients
• PET scans from individuals with early-stage disease

As a result, the study provides strong and consistent evidence across different models. This multi-level validation strengthens the reliability of the conclusions.

💡 Implications for Early Diagnosis and Treatment

The discovery has significant implications for diagnosing Alzheimer’s at an earlier stage.

Currently, treatments such as amyloid-beta antibodies are most effective when used early. Therefore, identifying patients before symptoms appear is critical.

This research suggests that monitoring changes in smell could become a simple and effective screening tool.

In addition, earlier detection could allow doctors to start treatment sooner, potentially improving outcomes.

🌍 New Direction for Alzheimer’s Research

The findings also open new directions for scientific research. Understanding how immune cells interact with neurons could lead to new therapeutic strategies.

At the same time, the study challenges previous assumptions about Alzheimer’s progression. Instead of focusing only on memory decline, researchers now recognise that sensory changes play a crucial role.

Consequently, future research may explore how to protect nerve connections and prevent early damage.

🔍 Future Outlook

Scientists will continue to investigate how these early changes can be used in clinical practice. Further studies may help develop non-invasive tests based on smell function.

For now, the discovery provides a powerful insight into Alzheimer’s disease. It also highlights the potential for earlier and more effective intervention.